| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2004 | WO2002085342A3 Use of nsaids for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
| 01/15/2004 | WO2002080888A3 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 01/15/2004 | WO2002078637A9 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002072105A9 Improved prostanoid therapies for the treatment of glaucoma |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010218 Injecting an aberrant tissue-selective photosensitizer into the bloodstream, exposing the aberrant tissue to light to activate the photosensitizer which increases the permeablitiy of the vasculature; injecting a chemotherapeutic agent |
| 01/15/2004 | US20040010151 Lansoprazole polymorphs and processes for preparation thereof |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010147 Cyclic amine compounds and pharmaceutical composition containing the same |
| 01/15/2004 | US20040010146 Process for the preparation imidazo[1,2-A]pyridine-3-acetamides |
| 01/15/2004 | US20040010143 Viricides |
| 01/15/2004 | US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders |
| 01/15/2004 | US20040010047 Synergistic mixture of anticholesterol agents and coenzyme Q-10 |
| 01/15/2004 | US20040010046 Cleaning compound, dentifrices; reducing microorganisms |
| 01/15/2004 | US20040010045 Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer |
| 01/15/2004 | US20040010044 Synergistic mixture of paracetamol, niflumic acid and excipients |
| 01/15/2004 | US20040010043 Treatment of cancers |
| 01/15/2004 | US20040010042 Method for preventing decrease of breast milk amount in mammals |
| 01/15/2004 | US20040010041 Administering cis retinoic acid |
| 01/15/2004 | US20040010038 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| 01/15/2004 | US20040010035 Gastrointestinal compositions |
| 01/15/2004 | US20040010034 Gastrointestinal compositions |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010025 Substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040010022 2-aminooxazole derivatives |
| 01/15/2004 | US20040010021 Administering famotidine or its therapeutically acceptable salts |
| 01/15/2004 | US20040010020 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010018 Treatment of neuropathic pain |
| 01/15/2004 | US20040010014 Novel compounds as opioid receptor modulators |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040010009 Excellent inhibitory activity against factor Xa |
| 01/15/2004 | US20040010008 Piperidine derivatives useful as CCR5 antagonists |
| 01/15/2004 | US20040010007 Also thio, sulfoxy and sulfonyl derivatives; imidazotetrazolopyrimidines and intermediates |
| 01/15/2004 | US20040010003 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040010001 Methods and compositions for modulating cell proliferation and cell death |
| 01/15/2004 | US20040010000 Methods and dosage forms for controlled delivery of oxycodone |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009997 Treating diseases in which HMG CoA reductase is implicated, such as hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 01/15/2004 | US20040009996 4-(1,2- or 2,1-benzoxazol-5-yl)-2-aminopyrimidines |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 01/15/2004 | US20040009993 Pyridopyrimidinones derivatives as telomerase inhibitors |
| 01/15/2004 | US20040009992 Azolylalkylazole derivatives, their preparation, and their use as pesticides |
| 01/15/2004 | US20040009991 Calcium channel antagonistic activity; especially useful as analgesics |
| 01/15/2004 | US20040009990 Especially piperidinylcarbonyl- and piperazinylcarbonyl-derivatives of indoles having oxalyl groups |
| 01/15/2004 | US20040009988 Inhibiting hepatic production of apoprotein B-100 and microsomal triglyceride transfer protein to decrease VLDL and chylomicrons production |
| 01/15/2004 | US20040009987 4-phenylpiperidinyl- or 4-phenylpiperazinyl-; including N-oxides |
| 01/15/2004 | US20040009986 Triglyceride depressant composition |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009980 Calcilytic compounds |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009978 Bicyclic or tricyclic fused pyrimidine derivatives or salts thereof which possess phosphatidylinositol 3 kinase (PI3K) inhibiting and antitumor activity |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009973 Novel potassium channels modulators |
| 01/15/2004 | US20040009971 Use of alprazolam in treatment of disorders of the central nervous system |
| 01/15/2004 | US20040009970 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009965 Treating hyperproliferative disorders |
| 01/15/2004 | US20040009963 Use of salmeterol and fluticasone propionate combination |
| 01/15/2004 | US20040009962 Combined estrogen blockade of the breast with exemestane and raloxifene |
| 01/15/2004 | US20040009961 Composition and therapies for hyperlipidaemia-associated disorders |
| 01/15/2004 | US20040009960 Drospirenone for hormone replacement therapy |
| 01/15/2004 | US20040009959 Thioether sulphamate steroids as steroid inhibtors and anti-cancer compounds |
| 01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
| 01/15/2004 | US20040009957 Limiting or reducing ischemic/reperfusion damage during surgical or interventional procedures, or during a heart attack; upregulating eNOS or iNOS proteins in order to precondition tissues or organs |
| 01/15/2004 | US20040009956 Treating type II diabetes and obesity |
| 01/15/2004 | US20040009955 Combating metastatic bone cancer with a polyphosphonate and a soluble radium-223 or - 224 salt or complex. |
| 01/15/2004 | US20040009954 Pharmaceutical composition for boron neutron capture therapy containing triphenylboroxin |
| 01/15/2004 | US20040009953 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| 01/15/2004 | US20040009952 Treatment of diabetic nephropathy; preferably a glycosaminoglycan, heparin or derivative, a hyaluronic acid, chondroitin sulfate or dermatin sulfate |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009949 Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids |
| 01/15/2004 | US20040009942 Administering a polynucleotide having an immunostimulatory sequence comprising the sequence 5'-C, G-3'; a respiratory virus antigen is not administered |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009930 Macrolide antibiotics |
| 01/15/2004 | US20040009929 Nasal delivery of parasiticides |
| 01/15/2004 | US20040009928 Isolation from a new marine microbe, strain PO13-046, belonging to the genus Actinomadura sp. |
| 01/15/2004 | US20040009927 Administering a control agent which inhibits the interaction of cAMP and CRP or inhibits cAMP synthesis or enhancing biofilm formation by administering cAMP or a cAMP analogue which enhances the interaction of cAMP and CRP. |
| 01/15/2004 | US20040009926 Geriatric depression is treated with L-carnitine or an alkanoyl L-carnitine or salt, preferably acetyl L-carnitine thereby avoiding unwanted side-effects exhibited by conventional antidepressant agents. |
| 01/15/2004 | US20040009924 Anticancer products for treating cystic fibrosis |
| 01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 01/15/2004 | US20040009906 Induction of antigen specific immunologic tolerance |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009898 Delivery vehicle construct comprising a cargo portion that is preferably a nucleic acid encoding a CFTR, and a u7-peptide portion. |
| 01/15/2004 | US20040009895 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 01/15/2004 | US20040009893 Ophthalmic lubricating solution adapted for use in lasik surgery |